Journal club

Breast Cancer

Explore All >

Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study

EMERALD lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Virginia Kaklamani

EMERALD Ph III Study in discussion w/(now FDA Approved) Dr. Aditya Bardia

DESTINY-Breast04 Study Discussion with Dr. Shanu Modi

GI

Explore All >

FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer

MOUNTAINEER Study in discussion w/ Dr. Tanios Bekaii-Saab

The NICHE-2 Study Discussion with Dr. Myriam Chalabi

GU

Explore All >

Breakthrough in Bladder Cancer: FDA approval – Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles

EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + Pembrolizumab

Hematology

Explore All >

How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes

Zanubrutinib – FDA Approval, Efficacy & Safety Profile – Discussion with Dr. Shadman

Polatuzumab FDA Approval in DLBCL (POLARIX) & SWOG S1826 Nivo vs. BV in Hodgkin’s Lymphoma Dr. Jonathan Friedberg